Prior to general anesthesia and surgery which oral hypoglycemic drug should be discontinued?
First, I remember that certain diabetes medications can pose risks during surgery, especially related to hypoglycemia or interactions with anesthesia. The main drugs used for type 2 diabetes are metformin, sulfonylureas like glyburide, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, and GLP-1 agonists.
Metformin is generally considered safe, but there's a concern about lactic acidosis in the context of surgery, especially if there's renal impairment or contrast dye use. However, guidelines usually say to hold metformin before procedures involving iodinated contrast, not necessarily all surgeries.
Sulfonylureas, such as glipizide or glyburide, have a longer duration of action and can cause hypoglycemia, especially if the patient is NPO (nothing by mouth) before surgery. They might need to be stopped a day before surgery to prevent intraoperative hypoglycemia.
Thiazolidinediones like pioglitazone can cause fluid retention, which might be a concern in heart failure, but not specifically related to surgery timing.
SGLT2 inhibitors, like canagliflozin, have a risk of euglycemic DKA and might need to be stopped before surgery, but I'm not sure if that's the main concern here.
GLP-1 receptor agonists are usually held before surgery, but again, the main issue is more about hypoglycemia or interactions with anesthesia.
Wait, the key here is which drug is specifically contraindicated or needs to be discontinued before surgery. I think sulfonylureas are a classic example because they can cause hypoglycemia during fasting. So the correct answer would be a sulfonylurea. Let me check: glyburide is a sulfonylurea. So if the options include glyburide, that's the one to stop.
Other options like metformin are held only if there's renal issues or contrast dye. SGLT2 inhibitors are held for DKA risk. Thiazolidinediones are held for fluid retention. But the main one to stop pre-op is sulfonylureas because of hypoglycemia risk during fasting. So the correct answer is glyburide (assuming that's an option).
Therefore, the correct answer is the sulfonylurea class drug. If the options include glyburide, that's the one to pick.
**Core Concept**
Oral hypoglycemic drugs with prolonged hypoglycemic effects or interactions with fasting/insulin resistance during surgery must be discontinued preoperatively. Sulfonylureas (e.g., glyburide) are particularly high-risk due to their mechanism of insulin secretion stimulation, which persists during fasting.
**Why the Correct Answer is Right**
Sulfonylureas (e.g., glyburide) bind to β-cell ATP-sensitive potassium channels, causing sustained insulin release. During surgical fasting, this can lead to **intraoperative hypoglycemia** and delayed glucose